UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatocyte growth factor/MET in cancer progression and biomarker discovery

Cancer science, 2017-03, Vol.108 (3), p.296-307

2017

Volltextzugriff (PDF)

Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer

Nature communications, 2020-09, Vol.11 (1), p.4607-14, Article 4607

2020

Volltextzugriff (PDF)

Hepatocyte growth factor in physiology and infectious diseases

Cytokine (Philadelphia, Pa.), 2017-10, Vol.98, p.97-106

2017

Volltextzugriff (PDF)

Hepatocyte growth factor twenty years on: Much more than a growth factor

Journal of gastroenterology and hepatology, 2011-01, Vol.26 (s1), p.188-202

2011

Volltextzugriff (PDF)

Hepatocyte growth factor and the Met system as a mediator of tumor–stromal interactions

International journal of cancer, 2006-08, Vol.119 (3), p.477-483

2006

Volltextzugriff (PDF)

Hepatocyte growth factor and Met in drug discovery

Journal of biochemistry (Tokyo), 2015-05, Vol.157 (5), p.271-284

2015

Volltextzugriff (PDF)

Lasso-grafting of macrocyclic peptide pharmacophores yields multi-functional proteins

Nature communications, 2021-03, Vol.12 (1), p.1543-1543, Article 1543

2021

Volltextzugriff (PDF)

N‐glycosylation regulates MET processing and signaling

Cancer science, 2022-04, Vol.113 (4), p.1292-1304

2022

Volltextzugriff (PDF)

Non-Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases

Cancer research (Chicago, Ill.), 2016-03, Vol.76 (6), p.1506-1516

2016

Volltextzugriff (PDF)

Artificial human Met agonists based on macrocycle scaffolds

Nature communications, 2015-03, Vol.6 (1), p.6373-6373, Article 6373

2015

Volltextzugriff (PDF)

Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Clinical cancer research, 2009-11, Vol.15 (21), p.6630-6638

2009

Volltextzugriff (PDF)

Dimer Interface in Natural Variant NK1 Is Dispensable for HGF-Dependent Met Receptor Activation

International journal of molecular sciences, 2021-08, Vol.22 (17), p.9240

2021

Volltextzugriff (PDF)

NK4 (HGF‐antagonist/angiogenesis inhibitor) in cancer biology and therapeutics

Cancer science, 2003-04, Vol.94 (4), p.321-327

2003

Volltextzugriff (PDF)

Dual blockade of MET and VEGFR2 signaling pathways as a potential therapeutic maneuver for peritoneal carcinomatosis in scirrhous gastric cancer

Biochemical and biophysical research communications, 2022-04, Vol.600, p.80-86

2022

Volltextzugriff (PDF)

Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases

Kidney international, 2001-06, Vol.59 (6), p.2023

2001

Volltextzugriff (PDF)

Impaired ligand‐dependent MET activation caused by an extracellular SEMA domain missense mutation in lung cancer

Cancer science, 2019-10, Vol.110 (10), p.3340-3349

2019

Volltextzugriff (PDF)

SRC kinase activator CDCP1 promotes hepatocyte growth factor–induced cell migration/invasion of a subset of breast cancer cells

The Journal of biological chemistry, 2022-03, Vol.298 (3), p.101630-101630, Article 101630

2022

Volltextzugriff (PDF)

Two-Chain Mature Hepatocyte Growth Factor-Specific Positron Emission Tomography Imaging in Tumors Using 64Cu-Labeled HiP-8, a Nonstandard Macrocyclic Peptide Probe

Molecular pharmaceutics, 2023-04, Vol.20 (4), p.2029-2038

2023

Volltextzugriff (PDF)

Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice

Molecular brain, 2009-03, Vol.2 (1), p.8-8, Article 8

2009

Volltextzugriff (PDF)

Macrocyclic Peptide-Conjugated Tip for Fast and Selective Molecular Recognition Imaging by High-Speed Atomic Force Microscopy

ACS applied materials & interfaces, 2021-11, Vol.13 (46), p.54817-54829

2021

Volltextzugriff (PDF)

Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer

Proceedings of the National Academy of Sciences - PNAS, 2017-10, Vol.114 (41), p.E8685-E8694

2017

Volltextzugriff (PDF)

Recent Insights into Human Endometrial Peptidases in Blastocyst Implantation via Shedding of Microvesicles

International journal of molecular sciences, 2021-12, Vol.22 (24), p.13479

2021

Volltextzugriff (PDF)

Leukocyte cell-derived chemotaxin 2 is an antiviral regulator acting through the proto-oncogene MET

Nature communications, 2022-06, Vol.13 (1), p.3176-3176, Article 3176

2022

Volltextzugriff (PDF)

Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases

Kidney international, 2001-06, Vol.59 (6), p.2023-2038

2001

Volltextzugriff (PDF)

Paracrine Receptor Activation by Microenvironment Triggers Bypass Survival Signals and ALK Inhibitor Resistance in EML4-ALK Lung Cancer Cells

Clinical cancer research, 2012-07, Vol.18 (13), p.3592-3602

2012

Volltextzugriff (PDF)

1 – 25 von 996

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(817)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(598)
Life Sciences & Biomedicine
(503)
Humans
(370)
Animals
(335)
Biological And Medical Sciences
(240)
Male
(206)
Female
(165)
Medical Sciences
(158)
Mice
(153)
Biochemistry & Molecular Biology
(121)
Hepatocyte Growth Factor
(118)
Rats
(108)
Hepatocyte Growth Factor - Pharmacology
(99)
Oncology
(96)
Fundamental And Applied Biological Sciences. Psychology
(93)
Hepatocyte Growth Factor - Genetics
(83)
Hepatocyte Growth Factor - Metabolism
(83)
Physical Sciences
(77)
Middle Aged
(69)
Proto-Oncogene Proteins C-Met - Metabolism
(67)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(627)
MEDLINE
(534)
Ingenta
(354)
Journals@Ovid Full Text
(278)
Publisher or Other Site
(211)
Elsevier ScienceDirect Journals Complete
(185)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(169)
Wiley Online Library
(141)
IngentaConnect Journals
(138)
Wiley Online Library
(85)
Springer Online Journals
(76)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(53)
Oxford Journals
(52)
Taylor & Francis Journals Complete
(32)
Nature
(31)
Taylor & Francis
(26)
Nexis Uni (LexisNexis)
(25)
Access via Taylor & Francis
(25)
JSTOR All Journals
(22)
SAGE Journals
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Hepatocyte growth factor/MET in cancer progression and biomarker discovery

Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer

Hepatocyte growth factor in physiology and infectious diseases

Hepatocyte growth factor twenty years on: Much more than a growth factor

Hepatocyte growth factor and the Met system as a mediator of tumor–stromal interactions

Hepatocyte growth factor and Met in drug discovery

Lasso-grafting of macrocyclic peptide pharmacophores yields multi-functional proteins

N‐glycosylation regulates MET processing and signaling

Non-Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases

Artificial human Met agonists based on macrocycle scaffolds

Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Dimer Interface in Natural Variant NK1 Is Dispensable for HGF-Dependent Met Receptor Activation

NK4 (HGF‐antagonist/angiogenesis inhibitor) in cancer biology and therapeutics

Dual blockade of MET and VEGFR2 signaling pathways as a potential therapeutic maneuver for peritoneal carcinomatosis in scirrhous gastric cancer

Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases

Impaired ligand‐dependent MET activation caused by an extracellular SEMA domain missense mutation in lung cancer

SRC kinase activator CDCP1 promotes hepatocyte growth factor–induced cell migration/invasion of a subset of breast cancer cells

Two-Chain Mature Hepatocyte Growth Factor-Specific Positron Emission Tomography Imaging in Tumors Using 64Cu-Labeled HiP-8, a Nonstandard Macrocyclic Peptide Probe

Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice

Macrocyclic Peptide-Conjugated Tip for Fast and Selective Molecular Recognition Imaging by High-Speed Atomic Force Microscopy

Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer

Recent Insights into Human Endometrial Peptidases in Blastocyst Implantation via Shedding of Microvesicles

Leukocyte cell-derived chemotaxin 2 is an antiviral regulator acting through the proto-oncogene MET

Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases

Paracrine Receptor Activation by Microenvironment Triggers Bypass Survival Signals and ALK Inhibitor Resistance in EML4-ALK Lung Cancer Cells

Aktive Filter

Suchergebnisse filtern